// App-Quantinova.ai

4977 : Immunogenic chemotherapy synergize PD-1 blockade by enhancing dendritic cells infiltration in triple-negative breast cancer (TNBC)

Researchers

Presenter

  • Xiangliang Yuan

Principal Investigators

  • Yi Xiao

  • Wenling Kuo

  • Dihua Yu

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Lung Cancer

  • Breast cancer

  • Solid malignancies

  • Melanoma

Biomarkers

  • Cluster of Differentiation 4

  • Programmed death-ligand 1

  • Type 1 T helper

Drug/Treatment

  • Doxorubicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved